AVIR Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 birž. 2024 @ 23:00):
Our systems believe the stock currently is overvalued by -0.29% compare to its pairs and should correct downwards.

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections...

Stats
Dzisiejszy wolumen	198 139
Średni wolumen	263 600
Kapitalizacja rynkowa	293.94M
EPS	$-0.750 ( Q1 \| 2024-05-14 )
Następna data zysków	( $-0.770 ) 2024-08-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.790 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00200 (0.06%)

AADI 3.55%

ABCL -3.79%

ABCM 0.04%

ABEO -5.02%

ABIO -0.29%

ABOS -3.03%

ABSI 0.66%

ABUS 0.66%

ABVX 2.61%

ACAD 3.79%

ACER -17.95%

ACET 9.49%

ACGN 1.29%

ACHL 0.22%

ACHV -4.83%

ACIU 2.47%

ACLX -0.09%

ACRV -5.30%

ACST -0.31%

ACXP -2.15%

ADAG 0.69%

ADAP -1.06%

ADGI 0.87%

ADIL 2.68%

ADMA 0.09%

ADPT 1.54%

ADTX -2.08%

ADVM 1.63%

ADXN -5.75%

AEON -7.34%

AEZS -1.10%

AFMD 1.02%

AGEN 4.60%

AGIO 0.02%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -0.69%

AKRO 2.80%

AKTX -1.08%

AKUS 0.00%

ALBO 0.00%

ALDX -5.46%

ALEC 0.44%

ALGS -4.88%

ALKS -1.28%

ALLK 8.11%

ALLO 2.35%

ALLR -28.40%

ALNA 3.16%

ALNY 34.52%

ALPN 0.02%

ALPX 0.00%

ALRN -1.60%

ALT 11.39%

ALVR 4.92%

ALXN 0.00%

ALXO -0.15%

ALZN -7.26%

AMRN 2.72%

AMTI -3.13%

ANAB 0.21%

ANEB -1.49%

ANGN 0.00%

ANIX -0.79%

ANL 0.29%

ANNX -4.22%

ANPC -3.15%

APGE 2.63%

APGN 8.48%

APGNW 30.65%

APLM 9.95%

APLS 0.92%

APLT 1.76%

APM 1.73%

APOP 0.38%

APRE 3.24%

APTO -2.37%

APTX 3.17%

APVO 1.15%

ARAV -13.39%

ARCT -0.44%

ARDS 2.49%

ARDX 1.46%

ARGX 11.69%

ARNA 0.00%

ARPO -0.90%

ARQT 4.59%

ARTL -2.71%

ARTLW 0.00%

ARVN -0.99%

ARWR 6.82%

ASLN -2.99%

ASMB 0.38%

ASND 1.20%

ATAI 4.48%

ATHA 1.28%

ATHE 2.27%

ATHX -33.50%

ATNF 2.05%

ATOS -5.31%

ATRA 0.67%

ATXI 9.52%

ATXS -2.65%

AUPH 2.35%

AURA -1.25%

AUTL -2.87%

AVBP -0.78%

AVEO 0.00%

AVIR 1.45%

AVRO -1.41%

AVTE -3.85%

AVTX 2.99%

AVXL 3.19%

AXLA 0.00%

AXSM 2.76%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO -15.94%

BCAB 3.31%

BCDA -5.67%

BCDAW -39.75%

BCEL 0.00%

BCLI 2.70%

BCRX -2.34%

BCTX -7.44%

BCTXW -18.26%

BCYC 0.10%

BDRX -15.63%

BDTX 0.83%

BEAM 8.24%

BFRA -2.91%

BGNE 1.95%

BIOR 1.50%

BIVI 0.96%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX 3.39%

BLTE 0.27%

BLU 0.03%

BLUE 13.45%

BMEA 5.51%

BMRN 1.62%

BNOX 2.99%

BNTC 4.80%

BNTX 2.33%

BOLD 13.42%

BOLT -1.45%

BPMC 1.79%

BPTH 0.88%

BPTS -13.47%

BRNS 0.00%

BRTX 1.72%

BTAI 4.39%

BTTX 0.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI -1.78%

CABA -1.53%

CADL 1.82%

CALA 0.00%

CALC -1.87%

CALT 1.83%

CAPR 1.91%

CARA 22.71%

CARM 9.80%

CASI 7.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -4.40%

CCCC 11.08%

CCXI 0.00%

CDAK 0.00%

CDIO -0.17%

CDIOW 36.86%

CDMO -4.38%

CDMOP 0.04%

CDT -7.05%

CDTTW -23.91%

CDTX -2.84%

CDXC -6.59%

CDXS 2.04%

CELC 4.58%

CELU 0.66%

CELUW 11.18%

CERC -1.68%

CERE -0.55%

CERO 2.09%

CEROW -22.90%

CFRX -27.95%

CGEM -0.34%

CGEN -5.08%

CGON 1.50%

CGTX -2.63%

CHMA -6.00%

CHRS -2.40%

CINC 0.00%

CING 4.73%

CINGW 73.79%

CKPT 15.56%

CLBS -16.75%

CLDX 2.55%

CLGN 6.22%

CLLS 1.06%

CLNN -3.46%

CLNNW -33.25%

CLRB 0.00%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB 8.57%

CMND -7.59%

CMPI 0.00%

CMPX 0.91%

CMRA 0.00%

CMRAW 33.33%

CMRX 1.85%

CNCE 0.00%

CNSP 12.63%

CNST 0.00%

CNTA -2.31%

CNTB -6.25%

CNTX 0.93%

COCP -1.88%

COEPW 0.00%

COGT 1.14%

CORT 1.83%

COYA -2.48%

CPRX -1.28%

CRBP 2.42%

CRBU 8.72%

CRDF -3.67%

CRGX 4.50%

CRIS 3.02%

CRNX 0.18%

CRSP 3.02%

CRTX 2.63%

CRVO 0.40%

CRVS 2.81%

CSBR -1.20%

CTCX -7.84%

CTIC 0.06%

CTMX 3.10%

CTNM 3.23%

CTXR 4.68%

CUE 8.89%

CVAC 6.44%

CVKD 6.24%

CWBR 0.00%

CYAD -12.96%

CYCC -5.01%

CYCCP 4.03%

CYCN 6.69%

CYT -2.27%

CYTK 0.71%

CYTO 2.61%

DARE 1.96%

DAWN -1.10%

DBTX -0.81%

DBVT -1.80%

DFFN 10.28%

DICE 0.06%

DMAC 2.78%

DNLI 1.24%

DNTH -0.04%

DOMH -2.63%

DRMA 12.50%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.62%

DRTSW 0.00%

DRUG -3.77%

DSGN -0.59%

DTIL 0.85%

DYAI -9.66%

EARS -1.77%

EDIT -0.59%

EDSA -0.11%

EFTR -75.81%

EFTRW -96.33%

EIGR -9.21%

ELAB 0.86%

ELDN -4.40%

ELEV -4.30%

ELOX 0.00%

ELTX 6.89%

ELVN 1.87%

ELYM -8.69%

ENGN -9.67%

ENGNW -7.87%

ENLV 3.68%

ENOB 1.79%

ENSC 4.98%

ENTA 2.43%

ENTO -2.13%

ENTX 1.98%

ENVB 9.19%

EPIX -1.02%

EPRX 0.57%

EPZM 0.00%

EQ 2.52%

EQRX -2.09%

EQRXW 0.00%

ERAS 2.37%

ERNA -4.64%

ERYP 1.30%

ESLA -0.50%

ESLAW 0.00%

ETNB -0.82%

ETON -0.60%

ETTX 0.00%

EVAX -5.28%

EVGN -2.18%

EVLO 0.00%

EWTX -1.99%

EXAI -2.78%

EXEL 0.54%

EYEG 0.11%

EYEN 2.28%

EYPT 0.59%

FATE 2.13%

FBIO -3.95%

FBIOP 0.59%

FBLG 5.49%

FBRX 0.27%

FDMT 1.35%

FENC -1.09%

FGEN 6.19%

FHTX 0.38%

FIXX 0.77%

FMTX 0.00%

FNCH -6.77%

FOLD -0.89%

FREQ 4.76%

FRLN 0.15%

FRTX -4.51%

FSTX 0.00%

FTRE -0.65%

FULC -5.09%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -8.97%

GANX 0.00%

GBIO 1.45%

GBT 0.01%

GDTC 5.61%

GERN -1.29%

GHRS 0.42%

GLMD -1.83%

GLPG 1.67%

GLSI -4.73%

GLTO 5.51%

GLUE 4.96%

GLYC 3.61%

GMAB -0.81%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT 1.29%

GNLX 10.68%

GNPX 0.00%

GNTA 7.74%

GOSS 27.09%

GOVX 30.04%

GOVXW 49.24%

GPCR -4.15%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 4.76%

GRTX 40.48%

GTHX -10.48%

GUTS 5.77%

GXGXW 41.67%

GYRE -3.28%

HALO 0.99%

HARP 0.09%

HCWB 10.69%

HEPA 5.42%

HGEN -84.62%

HILS 5.66%

HLVX 2.75%

HOOK -1.07%

HOTH 0.67%

HOWL -9.38%

HRMY -0.10%

HRTX -1.55%

HSTO 0.00%

HUMA -1.35%

HUMAW 5.19%

IBRX 1.10%

ICCC -0.22%

ICPT 0.21%

ICU 10.12%

ICUCW 14.68%

ICVX -0.91%

IDRA -23.04%

IDYA 0.03%

IFRX 8.44%

IGMS 0.00%

IKNA -2.33%

IKT -5.00%

IMAB 2.38%

IMCR -0.28%

IMGN 0.02%

IMGO 0.00%

IMMP -2.92%

IMMX 11.76%

IMNM -4.02%

IMNN -4.46%

IMPL -27.27%

IMRA 15.96%

IMRN 12.11%

IMRX 4.20%

IMTX -1.37%

IMTXW -14.50%

IMUX -0.90%

IMV 0.00%

IMVT 0.18%

INAB -0.84%

INBX 2.18%

INCY 0.84%

INDP -1.33%

INFI -52.38%

INKT -1.62%

INM 9.72%

INMB 1.62%

INO -1.61%

INSM 0.65%

INTS 4.74%

INVA 0.63%

INZY 0.67%

IOBT 0.00%

IONS 6.81%

IOVA 1.87%

IPA -1.92%

IPHA -5.16%

IPSC -6.29%

IRON 1.81%

ISEE 0.38%

ITOS 0.61%

ITRM -5.65%

IVA -0.71%

IVVD 2.42%

JAGX -3.32%

JANX 5.52%

JAZZ 1.72%

JNCE 0.00%

JSPR 1.72%

JSPRW 4.71%

JUNS 0.00%

JUNSW 0.00%

KA 13.13%

KALV -0.17%

KDNY 0.22%

KMPH -0.34%

KNSA 1.40%

KNTE -0.38%

KOD 3.41%

KPRX 9.68%

KPTI 12.76%

KRBP -0.40%

KRON -6.48%

KROS 0.09%

KRRO -0.76%

KRTX 0.03%

KRYS 1.97%

KTRA 6.15%

KTTA 4.85%

KTTAW -5.17%

KURA 0.67%

KYMR -1.69%

KYTX 2.07%

KZIA -15.51%

KZR 1.12%

LABP 0.57%

LBPH 0.05%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.13%

LENZ -1.52%

LEXX -1.49%

LEXXW -0.19%

LGND 0.72%

LGNDV 0.00%

LGVN -12.73%

LIAN -8.28%

LIFE 2.70%

LIPO 10.88%

LIXT -1.57%

LIXTW 0.00%

LJPC -0.32%

LMNL 0.12%

LOGC 1.27%

LPCN 3.56%

LPTX -2.08%

LQDA 3.28%

LRMR -10.33%

LSTA -3.26%

LTRN -5.78%

LUMO 1.79%

LVTX 0.27%

LXEO 4.94%

LXRX -2.16%

LYEL 3.41%

LYRA -2.78%

MACK 0.10%

MBIO 2.70%

MBRX -3.48%

MCRB -2.19%

MDGL 2.00%

MDNA -13.16%

MDWD 7.88%

MDXG -1.02%

MEIP -2.80%

MESO -3.28%

MGNX 2.97%

MGTA -7.74%

MGTX -3.18%

MGX 0.56%

MIRM 8.74%

MIRO 0.59%

MIST 0.72%

MITO 0.00%

MLEC -5.36%

MLECW 90.24%

MLND -5.36%

MLTX 0.73%

MLYS 4.90%

MNKD 6.26%

MNMD 0.27%

MNOV 0.00%

MNPR 15.76%

MOLN -25.10%

MOR -0.11%

MORF 10.26%

MREO -5.53%

MRKR 9.03%

MRNA 2.70%

MRNS 3.01%

MRSN 3.76%

MRTX -0.17%

MRUS 3.77%

MRVI -2.35%

MTCR -1.29%

MTEM -4.59%

MTP -18.50%

MURA -0.62%

MYMD -4.12%

NAMS 8.93%

NAMSW 26.87%

NAUT -8.57%

NBRV 0.71%

NBSE -1.56%

NBTX 4.81%

NCNA -0.34%

NERV -5.52%

NEXI -2.44%

NGM -1.28%

NGNE 2.39%

NKGN 0.00%

NKGNW 8.00%

NKTR 0.86%

NKTX 1.82%

NLSP -5.16%

NLSPW 28.30%

NMRA 0.00%

NMTR -42.97%

NOVN -24.84%

NRBO 0.49%

NRIX -1.27%

NRSN -3.99%

NRSNW 0.00%

NRXP 0.75%

NRXPW 0.00%

NRXS -0.78%

NTBL 0.36%

NTEC -12.45%

NTHI 0.00%

NTLA 3.22%

NTRBW 0.00%

NUVL 1.72%

NVAX 0.14%

NVCT 2.13%

NVIV -34.28%

NXTC 3.70%

NYMX -0.05%

OABI 1.75%

OABIW -3.65%

OBIO 9.02%

OBSV 0.00%

OCEA 7.75%

OCGN -5.26%

OCS 1.37%

OCUL 4.48%

OCUP 1.27%

ODT -4.27%

OKYO -1.63%

OLMA 2.15%

OMER 2.90%

OMGA -0.41%

ONCO -6.85%

ONCR -3.08%

ONCS 31.87%

ONCT -1.85%

ONCY 0.00%

ONTX -0.47%

ONVO -2.28%

OPNT 0.00%

OPT -4.93%

ORGS -3.25%

ORIC -1.11%

ORMP -3.04%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.62%

OVID 1.28%

OYST 0.00%

PALI -3.95%

PASG 0.00%

PBLA -4.76%

PBM -4.74%

PBYI -2.34%

PCSA 0.51%

PCVX 1.12%

PDSB 8.33%

PEPG 4.57%

PGEN 4.55%

PHAR 13.76%

PHAS 0.00%

PHAT -2.26%

PHIO 3.65%

PHIOW 36.47%

PHVS -4.62%

PHXM -5.20%

PIRS -5.56%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 3.28%

PLUR -0.44%

PMN -0.63%

PMVP 4.64%

PNT 0.16%

PPBT 5.78%

PRAX -2.61%

PRDS 0.93%

PRLD 2.88%

PROG -3.47%

PROK -7.60%

PRQR -3.51%

PRTA 0.56%

PRTC -6.90%

PRTG -0.04%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -11.11%

PSTX -1.08%

PTCT -2.05%

PTE -0.82%

PTGX -0.78%

PTIXW -5.10%

PULM -2.53%

PXMD 0.00%

PYPD -1.97%

PYXS -5.34%

QLGN -8.10%

QNCX 0.71%

QNRX 1.44%

QSI 0.84%

QSIAW 1.20%

QTTB -0.71%

QURE -1.09%

RAIN -1.63%

RANI -0.96%

RAPT 3.18%

RARE -0.45%

RCKT 7.03%

REGN 1.02%

RENB 1.27%

REPL 3.06%

RETA 0.02%

REUN -0.89%

REVB 13.74%

REVBU 3.46%

REVBW 50.29%

RGLS -18.33%

RGNX 6.41%

RIGL 0.65%

RLAY -0.58%

RLMD -0.99%

RLYB 5.48%

RNA 1.69%

RNAC 1.05%

RNAZ 5.27%

RNXT 4.09%

ROIV 2.06%

ROIVW 4.56%

RPHM 0.00%

RPRX 0.74%

RPTX 0.28%

RUBY 2.70%

RVLP -32.05%

RVMD 0.76%

RVMDW 17.51%

RVNC -3.38%

RVPH 2.40%

RVPHW 1.92%

RXDX 0.09%

RXRX 5.54%

RYTM 1.58%

RYZB 0.02%

RZLT 7.85%

SABS 4.23%

SABSW -35.81%

SAGE 3.86%

SANA 0.54%

SAVA -1.10%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -6.67%

SCPH 1.24%

SCPS 0.00%

SEEL -2.49%

SEER 1.76%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 5.62%

SGMT 6.87%

SGTX -2.56%

SIOX 22.63%

SLDB 2.48%

SLGL 0.59%

SLN 3.61%

SLNO -2.60%

SLRX -3.97%

SLS -0.82%

SMMT 0.88%

SNDX -1.25%

SNGX -2.31%

SNPX 5.67%

SONN -6.53%

SPPI -0.49%

SPRB 5.39%

SPRC -2.42%

SPRO -2.92%

SRNE 15.79%

SRPT 1.95%

SRRA 0.00%

SRRK -0.47%

SRZN 5.26%

STAB 0.00%

STOK 0.70%

STRO -4.95%

STSA 0.00%

STTK -9.50%

SURF -0.93%

SVRA -5.67%

SWTX -0.17%

SYBX 2.01%

SYRS 4.12%

TALS -0.73%

TARA -1.33%

TARS 1.36%

TBPH 0.23%

TCBP -8.11%

TCDA 0.00%

TCON -1.60%

TCRR 0.00%

TCRT -3.84%

TCRX 2.92%

TECH 1.13%

TENX 9.03%

TERN 4.01%

TFFP 9.20%

TGTX 4.31%

THRX 0.12%

TIL -3.68%

TLC 0.00%

TLSA 14.49%

TNGX 0.50%

TNXP -8.46%

TNYA -0.96%

TPST 2.96%

TRDA -4.11%

TRVI -2.22%

TRVN -13.99%

TSHA -10.14%

TSVT 3.76%

TTNP -14.84%

TVTX 6.57%

TYRA 0.35%

UBX 0.36%

UNCY 7.44%

URGN 5.81%

UTHR 0.92%

VACC 11.36%

VALN 12.99%

VAXX -10.53%

VBIV 3.44%

VBLT -8.77%

VCEL 2.64%

VCNX -0.49%

VCYT 1.77%

VERA -2.79%

VERU 9.04%

VERV -0.19%

VIGL 0.52%

VINC -1.38%

VIR 0.22%

VIRI -1.85%

VIRX -5.63%

VKTX -1.18%

VLON -13.04%

VNDA -2.29%

VOR 4.20%

VRCA -4.56%

VRDN 5.09%

VRNA 4.60%

VRPX -4.95%

VRTX 1.33%

VSTM -1.90%

VTGN -3.58%

VTVT 0.00%

VTYX -0.80%

VXRT 5.82%

VYGR -0.43%

VYNE -4.95%

VYNT 7.78%

WINT 7.90%

WVE -0.76%

XBIO -5.83%

XBIT -12.02%

XCUR -3.35%

XENE -0.21%

XERS 0.00%

XFOR 0.00%

XLO 2.47%

XLRN 0.00%

XNCR 1.46%

XOMA 5.64%

XOMAO -0.20%

XOMAP -0.76%

XRTX -2.38%

YMAB 0.83%

ZGNX 0.00%

ZIOP -0.88%

ZLAB 0.97%

ZNTL -3.16%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-21	Duncan Barbara Gayle	Buy	41 200	Stock Option (Right to Buy)
2024-06-21	Duncan Barbara Gayle	Buy	29 600	Restricted Stock Units
2024-06-21	Berger Franklin M	Buy	41 200	Stock Option (Right to Buy)
2024-06-21	Berger Franklin M	Buy	29 600	Restricted Stock Units
2024-06-21	Adams Jerome M.	Buy	41 200	Stock Option (Right to Buy)

INSIDER POWER
66.22
Last 99 transactions
Buy: 8 269 912 \| Sell: 758 900

Korelacja (AI algo v.1.1b): Overvalued: -0.29% $3.49 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Wolumen Korelacja

Długi: 0.27 (neutral)

Krótki: -0.79 (moderate negative)

Signal:(67.503) Neutral

Atea Pharmaceuticals, Korelacja

10 Najbardziej pozytywne korelacje
OZEM	1
CCSB	0.906
NEWZ	0.901
GECCI	0.89
BWAQR	0.861
OPTZ	0.859
BOTT	0.855
NNAVW	0.847
EVERX	0.847
IDYA	0.843

10 Najbardziej negatywne korelacje
AMDL	-0.901
HPCO	-0.882
GDC	-0.874
OCEA	-0.868
PMNT	-0.864
BFRGW	-0.864
LBTYB	-0.864
ABLV	-0.861
LDTC	-0.858
ATPC	-0.856

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Atea Pharmaceuticals, Korelacja - Waluta/Towar

0.18
( neutral )

-0.09
( neutral )

0.00
( neutral )

0.52
( weak )

Atea Pharmaceuticals, Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-416 000 (0.00 %)
EPS:	$-1.630

FY	2023
Przychody:	$0
Zysk brutto:	$-416 000 (0.00 %)
EPS:	$-1.630

FY	2022
Przychody:	$0
Zysk brutto:	$-260 000 (0.00 %)
EPS:	$-1.390

FY	2021
Przychody:	$351.37M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$5.61

Financial Reports:

No articles found.

Atea Pharmaceuticals, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Atea Pharmaceuticals,

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of dengue; AT-777, an NS5A inhibitor; AT-787, a co-formulated, oral, pan-genotypic fixed dose combination of AT-527 and AT-777 for the treatment of hepatitis C virous (HCV); and AT-281, a pharmaceutically acceptable salt for the treatment or prevention of an RNA viral infection, including dengue fever, yellow fever, Zika virus, and coronaviridae viral infection, as well as Ruzasvir, an investigational oral, pan genotypic NS5A inhibitor for the treatment of chronic HCV infection. It has a license agreement with Merck & Co, Inc. for development and commercialization of ruzasvir for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.